Element Logic partners with Purdue University to add AutoStore to their Smart Lab
Element Logic will install an AutoStore system to act as a 'mock warehouse' within Purdue's Campus — home to a cutting-edge Smart Factory.
'Through Element Logic's integration, students now have real-time access to cutting-edge robotics and software that orchestrate order fulfillment with speed and precision.'— Parth Joshi, CPO at AutoStore
MELBOURNE, FL, UNITED STATES, June 4, 2025 / EINPresswire.com / -- Element Logic is proud to announce the implementation of an AutoStore system, summer 2025, at Purdue Polytechnic School of Engineering Technology's campus in West Lafayette, Ind.
Element Logic will install an AutoStore system to act as a 'mock warehouse' within Purdue's Campus — home to a cutting-edge Smart Factory. This is an important piece of Purdue University's commitment to driving innovation in automation and shaping the future of engineering education
'This collaboration with Element Logic will allow our students to interact directly with cutting-edge automation, gaining the skills and insights that will set them apart from day one in the workforce,' Daniel Castro, Dean of the Purdue Polytechnic, said.
The Smart Learning Factory is designed to provide hands-on experience and immersive learning to prepare the next generation of engineers for a highly competitive and technically demanding marketplace. Acting as a microcosm of modern industry, the facility integrates advanced technologies such as IoT-connected devices, AI-driven optimization, and cybersecurity tools—mirroring the digital and physical systems students will encounter in real-world smart manufacturing environments.
'At Purdue Polytechnic, we are committed to giving students access to the most advanced technologies shaping today's industries,' Castro added. 'The integration of AutoStore into our Smart Factory reflects our hands-on, real-world approach to education.'
The Smart Factory at Purdue brings together a fully integrated, flexible manufacturing environment—featuring several production machines, assembly lines, and now a highly efficient AutoStore system that will serve as the factory's dedicated warehouse solution.
'Integrating a top-tier, industrial-grade AS/RS in a compact educational facility is a challenging goal,' said Steve Musick, Smart Manufacturing Engineer for the Smart Learning Factory. 'AutoStore's leading-edge technology and proven scalability made it an ideal choice for our performance, space, and instructional requirements. Robert and the Element Logic team engaged with us immediately and were equally excited to turn this goal into a reality. Their global expertise in logistics and AutoStore integration makes them an invaluable partner for this deployment and for future endeavors.'
'Purdue's Smart Factory is already recognized as the nation's largest, most comprehensive smart-manufacturing learning ecosystem, and we're proud that a fully functioning AutoStore grid will now serve as its warehouse 'heart',' Robert Humphry, Executive Vice President at Element Logic, said. 'By giving students live access to the same cube-storage automation trusted by leading global retailers, we're turning classroom concepts into hands-on data, KPIs, and real-time problem solving.'
With access to the densest ASRS technology, Purdue University's students, faculty, and guests will be able to test and understand —first-hand — real-time capabilities of automation.
'Seeing our AutoStore system serve as the core warehouse solution within Purdue's Smart Factory is a great example of how automation can bring theory into practice.' Parth Joshi, CPO at AutoStore, said. 'Through Element Logic's integration, students now have real-time access to cutting-edge robotics and software that orchestrate order fulfillment with speed and precision.
'It's vital that tomorrow's engineers are exposed to world-class technologies like AutoStore early in their careers — this not only strengthens their practical skills,but also inspires them to explore how intelligent automation and data-driven systems can transform the way we design and operate future technologies,' Joshi added. 'This installation not only supports Purdue's forward-thinking approach to education but also reflects our commitment to empowering the next generation to move things forward.'
This hands-on access allows students to experience how cutting-edge automation technologies integrate into modern manufacturing environments—offering insights into efficiency, scalability, and sustainable operations.
'This system and the Smart Lab enable future engineers to experiment and develop skills they'll use on day one in the industry,' Humphry added. 'Element Logic couldn't ask for a better partner than Purdue University in preparing future generations to reimagine how goods move through tomorrow's supply chains.'
The AutoStore solution from Element Logic will operate as a fully functional component of the Smart Factory's logistics and materials management workflow.
About Purdue University
Purdue University is a public research university leading with excellence at scale. Ranked among top 10 public universities in the United States, Purdue discovers, disseminates and deploys knowledge with a quality and at a scale second to none. More than 107,000 students study at Purdue across multiple campuses, locations and modalities, including more than 58,000 at the main campus in West Lafayette and Indianapolis. Committed to affordability and accessibility, Purdue's main campus has frozen tuition 14 years in a row.
About Element Logic
Element Logic is a technology company that optimizes warehouses for customers to gain a competitive edge. The company was founded in 1985 and is headquartered in Norway. It operates worldwide and is the world's first and largest AutoStore partner. Element Logic offers its customers automated robotic solutions, software, and consulting services.
Gina Rotermund
Element Logic
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
Legal Disclaimer:
EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Boston Globe
2 days ago
- Boston Globe
Purdue Pharma's $7B opioid settlement is set for votes from victims and cities
Government entities, emergency room doctors, insurers, families of children born into withdrawal from the powerful prescription painkiller, individual victims and their families, and others will have until Sept. 30 to vote on whether to accept the deal. Advertisement The settlement is a way to avoid trials with claims from states alone that total more than $2 trillion in damages. Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up This month, 49 states announced they had signed on to the proposal. Only Oklahoma, which has a separate settlement with the company, is not involved. Massachusetts is in line for up to $105 million from the settlement, Attorney General Andrea Campbell said Tuesday. If approved, the settlement would be among the largest in a wave of lawsuits over the past decade as governments and others sought to hold drugmakers, wholesalers, and pharmacies accountable for the opioid epidemic that started rising in the years after OxyContin hit the market in 1996. The other settlements together are worth about $50 billion, and most of the money is to be used to combat the crisis. Advertisement In the early 2000s, most opioid deaths were linked to prescription drugs, including OxyContin. Since then, heroin and then illicitly produced fentanyl became the biggest killers. In some years, the class of drugs was linked to more than 80,000 deaths, but that number dropped sharply last year. Last year, the US Supreme Court rejected a version of Purdue's proposed settlement. The court found it was improper to protect members of the Sackler family from lawsuits over opioids, even though they themselves were not filing for bankruptcy protection. In the new version, groups that don't opt in to the settlement would still have the right to sue members of the wealthy family whose name once adorned museum galleries around the world, as well as programs at several prestigious US universities. Under the plan, the Sackler family members would give up ownership of Purdue. They resigned from the company's board and stopped receiving distributions from its funds before the company's initial bankruptcy filing in 2019. The remaining entity would get a new name and its profits would be dedicated to battling the epidemic. Most of the money would go to state and local governments to address the nation's addiction and overdose crisis, but potentially close to $900 million would go directly to individual victims. That makes it different from the other major settlements. The payments would not begin until after a hearing, likely in November, in which Lane would be asked to approve the entire plan if enough affected parties agree.
Business Wire
2 days ago
- Business Wire
Purdue Pharma L.P. Receives Court Approval of Disclosure Statement Filed in Connection with its Plan of Reorganization
STAMFORD, Conn.--(BUSINESS WIRE)--Purdue Pharma L.P. ('Purdue') today announced that the United States Bankruptcy Court for the Southern District of New York (the 'Bankruptcy Court') approved the Company's disclosure statement for its Chapter 11 Plan of Reorganization. The disclosure statement provides creditors with detailed information on the terms of the Plan and will accompany the ballots that will be sent to the more than 600,000 claimants eligible to vote. The court has set a September 30 voting deadline and a November confirmation hearing. 'Following the 2024 Supreme Court ruling, we doubled down on our commitment to work with our creditors to design a new Plan that delivers unprecedented value to those affected by the opioid crisis. Today's disclosure statement approval is a major milestone in that effort,' said Purdue Board Chairman Steve Miller. 'We and our creditors have worked tirelessly in mediation to build consensus and negotiate a settlement that will increase the total value provided to victims and communities, put billions of dollars to work on day one, and serve the public good. We sincerely thank our stakeholders for their dedication and collaboration, and we look forward to having the plan confirmed and consummated as quickly as possible.' Purdue's Plan of Reorganization includes the following elements: Assuming full creditor participation, the Sacklers will make settlement payments of approximately $6.5 billion in installments over the next 15 years, subject to certain reserves. They will pay $1.5 billion on the day the Plan becomes effective. Purdue will contribute 100% of its assets, with an expected $900 million in cash available for distribution on the day of emergence. Notably, the Plan is the only opioid settlement to date that meaningfully compensates individual victims. Assuming full participation, individual victims will receive more than $850 million. In addition to this cash value, the Plan creates a new company with a public minded mission. The new company will provide millions of doses of lifesaving opioid use disorder treatment and overdose reversal medicines at no profit. The Sacklers, who exited the Board of Purdue by the end of 2018 and have had no involvement in Purdue since that time, will have no role whatsoever in the new company. Purdue Pharma L.P. will be liquidated following emergence. The Plan also provides a historic level of transparency. It creates a document repository that will make available to the public millions of documents, including privileged documents, related to Purdue's historical sales and marketing practices. The Plan does not contain third-party releases and fully complies with the Supreme Court's June 2024 decision in Harrington. The disclosure statement approved today provides the full details about the material aspects of the plan. The Plan is subject to confirmation by the Bankruptcy Court. This release is not intended as a solicitation of a vote on the Plan. Purdue Pharma and its subsidiaries develop, manufacture and market medications to meet the evolving needs of healthcare professionals, patients, and caregivers. Purdue and its subsidiaries focus on balancing innovative science with clinically effective, compassionate care. The Company's goals are to serve patients who rely on its medicines, pursue public health initiatives intended to help abate the opioid crisis, advance its pipeline of branded and generic medications, and introduce medicines that will help save and improve lives.
Chicago Tribune
2 days ago
- Chicago Tribune
Purdue Pharma's $7B opioid settlement plan could get votes from victims and cities
OxyContin maker Purdue Pharma 's $7 billion-plus plan to settle thousands of lawsuits over the toll of opioids will go before a judge Friday, potentially setting up votes on whether to accept it for local governments, people who became addicted to the drug and other groups. This month, 49 states announced they have signed on to the the proposal. Only Oklahoma, which has a separate settlement with the company, is not involved. U.S. Bankruptcy Court Judge Sean Lane could decide as soon as Friday whether to advance the nationwide settlement, which was hammered out in negotiations between the company, groups that have sued and representatives of members of the Sackler family who own the company. If Lane moves the plan forward as it's been presented, government entities, emergency room doctors, insurers, families of children born into withdrawal from the powerful prescription painkiller, individual victims and their families and others would have until Sept. 30 to vote on whether to accept the deal. The settlement is a way to avoid trials with claims from states alone that total more than $2 trillion in damages. If approved, the settlement would be among the largest in a wave of lawsuits over the past decade as governments and others sought to hold drugmakers, wholesalers and pharmacies accountable for the opioid epidemic that started rising in the years after OxyContin hit the market in 1996. The other settlements together are worth about $50 billion, and most of the money is to be used to combat the crisis. In the early 2000s, most opioid deaths were linked to prescription drugs, including OxyContin. Since then, heroin and then illicitly produced fentanyl became the biggest killers. In some years, the class of drugs was linked to more than 80,000 deaths, but that number dropped sharply last year. Last year, the U.S. Supreme Court rejected a version of Purdue's proposed settlement. The court found it was improper to protect members of the Sackler family from lawsuits over opioids, even though they themselves were not filing for bankruptcy protection. In the new version, groups that don't opt in to the settlement would still have the right to sue members of the wealthy family whose name once adorned museum galleries around the world and programs at several prestigious U.S. universities. Under the plan, the Sackler family members would give up ownership of Purdue. They resigned from the company's board and stopped receiving distributions from its funds before the company's initial bankruptcy filing in 2019. The remaining entity would get a new name and its profits would be dedicated to battling the epidemic. Most of the money would go to state and local governments to address the nation's addiction and overdose crisis, but potentially more than $850 million would go directly to individual victims. That makes it different from the other major settlements. The payments would not begin until after a hearing, likely in November, during which Judge Lane would be asked to approve the entire plan if enough of the affected parties agree.
